Medtronic 55751024560 Instructions for Use

Page 1
CD Horizon™ Fenestrated Screw Set M708348B493E Rev. G
2020-09-29
IMPORTANT INFORMATION ON THE CD HORIZON™ FENESTRATED SCREW SET
PURPOSE
The CD Horizon™ Fenestrated Screw Set is intended to help provide immobilization and stabilization of spinal segments of the thoracic, lumbar, or sacral spine.
DESCRIPTION
The CD Horizon™ Fenestrated Screw Set consists of a variety of cannulated screws. These screws contain a series of fenestrations which allows polymethylmethacrylate (PMMA) bone cement (Medtronic HV-R™ Fenestrated Screw Cement or Kyphon™ Xpede™ Bone Cement) to be injected into the treated site. This cement is used to augment screw fixation into the pedicle in patients whose life expectancy is of insufficient duration to permit achievement of fusion.
These implants may also serve as traditional pedicle screws when used without bone cement in patients. CD Horizon™ Fenestrated Screws are specifically designed to connect to appropriate rods and associated connecting
components contained within the CD Horizon™ Spinal System. Refer to the CD Horizon™ Spinal System package insert for information regarding those implants. Care should be taken so the correct components are used in the spinal construct.
CD Horizon™ Fenestrated Screw Set implant components are fabricated from medical grade titanium and/or medical grade titanium alloy and/or medical grade cobalt-chromium-molybdenum alloy. Never use stainless steel and titanium implant components in the same construct.
To achieve best results, do not use CD Horizon™ Fenestrated Screw implants with components from any system other than the CD Horizon™ Spinal System. As with all orthopedic and neurosurgical implants, CD Horizon™ Fenestrated Screw implants should never be reused under any circumstances.
INDICATIONS
When used without cement, CD Horizon™ Fenestrated Screws (with or without Sextant™ or Longitude™ instrumentation) are intended for posterior, non-cervical fixation as an adjunct to fusion for the following indications: degenerative disc disease (DDD­defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies), spondylolisthesis, tumor and/or trauma (i.e. fracture or dislocation), spinal stenosis, curvatures (i.e. scoliosis, kyphosis, or lordosis), pseudarthrosis, and/or failed previous fusion.
Additionally, CD Horizon™ Fenestrated Screws may be used for immobilization and stabilization when used for trauma (e.g., fracture or dislocation) with the usage of bone graft material left to the surgeon’s discretion.
When used in conjunction with Medtronic HV-R™ Fenestrated Screw Cement or Kyphon™ Xpede™ Bone Cement, CD Horizon™ Fenestrated Screws are intended to restore the integrity of the spinal column even in the absence of fusion for a limited time in patients with advanced stage tumors involving the thoracic, lumbar, or sacral spine in whom life expectancy is of insufficient duration to permit achievement of fusion. CD Horizon™ Fenestrated Screws augmented with Medtronic HV-R™ Fenestrated Screw Cement or Kyphon™ Xpede™ Bone Cement are for use at spinal levels where the structural integrity of the spine is not severely compromised.
CONTRAINDICATIONS
Contraindications include:
Active infectious process or significant risk of infection (immunocompromise).Signs of local inflammation.Fever or leukocytosis.Morbid obesity.Pregnancy.Mental illness.Grossly distorted anatomy caused by congenital abnormalities.Any other medical or surgical condition which would preclude the potential benefit of spinal implant surgery such as the
presence of congenital abnormalities, elevation of sedimentation rate unexplained by other diseases, elevation of white blood count (WBC), or a marked left shift in the WBC differential count.
Suspected or documented metal allergy or intolerance.Pedicular/wall defects.An allergy or contraindication to PMMA cement (when used for the cement-related indications).
Page 2
Any case where implant components selected for use would be too large or too small to achieve a successful result.Any patient having inadequate tissue coverage over the operative site.Any patient in which implant use would interfere with anatomical structures or expected physiological performance.Any patient unwilling to follow postoperative instructions.Any case not described in the indications.Any patient with a T-score of > -2.5 (when cement-augmentation is utilized in patients with advanced staged tumors).
ADDITIONAL CONTRAINDICATIONS
(SPECIFIC TO PATIENTS OUTSIDE SCOPE OF PMMA USAGE INDICATIONS)
Nota bene: although not absolute contraindications, conditions to be considered as potential factors for not using this device include:
Severe bone resorption.Osteomalacia.Severe osteoporosis.
POTENTIAL ADVERSE EVENTS
All of the following adverse events associated with spinal surgery without instrumentation are possible. With instrumentation, a listing of potential adverse events includes:
Early or late loosening of any or all components.Disassembly, bending, and/or breakage of any or all components.Foreign body (allergic) reaction to implants, debris, corrosion products (from crevice, fretting, and/or general corrosion)
including metallosis, staining, tumor formation, and/or autoimmune disease.
Pressure on the skin from component parts in patients with inadequate tissue coverage over the implant possibly causing
skin penetration, irritation, fibrosis, necrosis, or pain.
Bursitis.Tissue or nerve damage caused by improper positioning and placement of implants or instruments.Post-operative change in spinal curvature, loss of correction, height, or reduction.Infection.Dural tears, pseudomeningocele, fistula, persistent CSF leakage, or meningitis.Loss of neurological function (e.g. sensory and/or motor) including paralysis (complete or incomplete), dysesthesias,
hyperesthesia, anesthesia, paresthesia, appearance of radiculopathy, and/or development or continuation of pain, numbness, neuroma, spasms, sensory loss, tingling sensation, and/or visual deficits.
Cauda equina syndrome, neuropathy, neurological deficits (transient or permanent), paraplegia, paraparesis, reflex deficits,
irritation, arachnoiditis, and/or muscle loss.
Urinary retention, loss of bladder control, or other types of urological and/or gastrointestinal system compromise.Scar formation possibly causing neurological compromise or compression around nerves and/or pain.Fracture, microfracture, resorption, damage, or penetration of any spinal bone (including the sacrum, pedicles, and/or
vertebral body).
Herniated nucleus pulposus, disc disruption, or degeneration at, above, or below the level of surgery.Loss of or increase in spinal mobility or function.Inability to perform activities of daily living.Bone loss or decrease in bone density, possibly caused by stresses shielding.Ileus, gastritis, bowel obstruction, loss of bowel control, or other types of gastrointestinal system compromise.Hemorrhage, hematoma, occlusion, seroma, edema, hypertension, embolism, stroke, excessive bleeding, phlebitis, wound
necrosis, wound dehiscence, damage to blood vessels, or other types of cardiovascular system compromise.
Development of respiratory problems (e.g. pulmonary embolism, atelectasis, bronchitis, pneumonia, etc).Change in mental status.Death.
Serious adverse events, some with fatal outcomes, associated with the use of acrylic bone cements in the spine include myocardial infarction, cardiac arrest, cerebrovascular accident, pulmonary embolism, and cardiac embolism. Although the majority of these adverse events present early with the post-operative period, there have been some reports of diagnoses beyond a year or more after the procedure.
Other reported adverse events for acrylic bone cements intended for use in the spine include leakage of the bone cement beyond the site of its intended application with introduction into the vascular system resulting in embolism of the lung and/or heart or other clinical sequelae.
Note: additional surgery may be necessary to correct some of these potential adverse events.
ADDITIONAL POTENTIAL ADVERSE EVENTS
(SPECIFIC TO PATIENTS OUTSIDE SCOPE OF PMMA USAGE INDICATIONS)
Fracture, microfracture, resorption, damage or penetration of any spinal bone (including the sacrum, pedicles, and/or
vertebral body) and/or bone graft or bone graft harvest site at, above, and/or below the level of surgery.
Retropulsed graft.Herniated nucleus pulposus, disc disruption or degeneration at, above, or below the level of surgery.
Page 3
Non-union (or pseudarthrosis), delayed union, and mal-union.Cessation of any potential growth of the operated portion of the spine.Graft donor site complications including pain, fracture, or wound healing problems.Reproductive system compromise, including sterility, loss of consortium and sexual dysfunction.
ADDITIONAL POTENTIAL ADVERSE EVENTS FOR PEDIATRIC PATIENTS
(SPECIFIC TO PEDIATRIC PATIENTS OUTSIDE SCOPE OF PMMA USAGE INDICATIONS)
Inability to use pedicle screw fixation due to anatomic limitations (pedicle dimensions, distorted anatomy).Pedicle screw malpositioning, with or without neurological or vascular injury.Proximal or distal junctional kyphosis.Pancreatitis.
WARNING
Safety and effectiveness of pedicle screw spinal systems have been established only for spinal conditions with significant mechanical instability or deformity requiring fusion with instrumentation. Safety and effectiveness of this device for any other conditions are unknown. The implants are not prostheses. In the absence of fusion, instrumentation and/or one or more of its components can be expected to pull out, bend, or fracture as a result of exposure to everyday mechanical stresses. Removal of these implants used to treat spinal fractures is left to the discretion of the physician and the patient.
A device that has been implanted should never be reused, reprocessed, or resterilized under any circumstances. Sterile packaged devices should also never be resterilized. Reuse, reprocessing, or resterilization may compromise the structural integrity of these implants and create a risk of contamination of the implants which could result in patient injury, illness, or death.
The following should be noted as warnings and precautions specific to the instruments used in the injection of cement:
Always use live imaging when injecting material.Cement leakage may cause tissue damage, nerve or circulatory problems, and other serious adverse events.
These risks may increase with the number of spinal levels where bone cement is used, and also with the volume of bone cement used.
ADDITIONAL WARNINGS FOR PEDIATRIC PATIENTS
(SPECIFIC TO PEDIATRIC PATIENTS OUTSIDE SCOPE OF PMMA USAGE INDICATIONS)
Safety and effectiveness of this device have not been established for use as part of a growing rod construct. This device is only intended to be used when definitive fusion is performed at all instrumented levels. Use of pedicle screw fixation in the pediatric population may present additional risks when patients are of smaller stature and skeletally immature. Pediatric patients may have smaller spinal structures (i.e. pedicle diameter or length) that may preclude the use of pedicle screws or increase the risk of pedicle screw malpositioning and neurological or vascular injury. Patients not skeletally mature that undergo spinal fusion procedures may have a reduced longitudinal spinal growth, or may be at risk for rotational spinal deformities (i.e. the “crankshaft phenomenon”) due to continued differential growth of the anterior spine. Other adverse events related to pedicle screw fixation, such as screw or rod bending, breakage, or loosening may also occur in pediatric patients. Pediatric patients may be at increased risk for device-related injury because of their smaller stature.
PRECAUTIONS
Implantation of pedicle screw spinal systems should be performed only by experienced spinal surgeons with specific training in the use of this pedicle screw spinal system because this is a technically demanding procedure presenting a risk of serious injury to the patient.
A successful result is not always achieved in every surgical case. This fact is especially true in spinal surgery where many extenuating circumstances may compromise the results. No spinal implant can withstand body loads without the support of bone. In this event, bending, loosening, disassembly, and/or breakage of the device(s) will eventually occur.
Preoperative and operating procedures, including knowledge of surgical techniques, good reduction, and proper selection and placement of implants are important considerations in the successful use of the system by the surgeon. Further, proper selection and compliance of the patient will greatly affect results.
Refer to the Medtronic HV-R™ Fenestrated Screw Cement or Kyphon™ Xpede™ Bone Cement Instructions for Use for cement related contraindications, potential adverse events, and warnings when using those specific cements.
ADDITIONAL PRECAUTIONS FOR PEDIATRIC PATIENTS
( SPECIFIC TO PEDIATRIC PATIENTS OUTSIDE SCOPE OF PMMA USAGE INDICATIONS)
Implantation of pedicle screw spinal systems in pediatric patients should be performed only by experienced spinal surgeons with specific training in the use of pedicle screw spinal system implants in pediatric patients because this is a technically demanding procedure presenting a risk of serious injury to the patient. Preoperative and operating procedures, including knowledge of surgical techniques, good reduction, and proper selection and placement of implants are important considerations in the successful use of the system in pediatric patients. The selection of the proper size, shape, and design of the implant for each patient is crucial to the safe use of this device in pediatric patients.
For US Audiences Only
Caution: Federal law (USA) restricts these devices to sale by or on the order of a physician.
Page 4
IMPLANT SELECTION
Selection of proper size, shape, and design of the implant for each patient is crucial to success of the procedure. Metallic surgical implants are subject to repeated stresses in use, and their strength is limited by the need to adapt the design to the size and shape of human bones. Unless great care is taken in patient selection, proper placement of the implant, and postoperative management to minimize stresses on the implant, such stresses may cause metal fatigue and consequent breakage, bending, or loosening of the device before the healing process is complete which may result in further injury or the need to remove the device prematurely.
PREOPERATIVE
Only patients that meet the criteria described in the indications should be selected.Patient conditions and/or predispositions such as those addressed in the contraindications should be avoided.Care should be used in handling and storage of implant components. Implants should not be scratched or otherwise
damaged. Implants and instruments should be protected during storage, especially from corrosive environments.
An adequate inventory of implants should be available at the time of surgery; normally a quantity in excess of what is
expected to be used.
Since mechanical parts are involved, the surgeon should be familiar with the various components before using the
equipment and should personally assemble the devices to verify all parts and necessary instruments are present. CD Horizon™ Spinal System components (described in the DESCRIPTION section) are not to be combined with components from another manufacturer.
Unless sterile packaged, all devices should be sterilized before use. Additional sterile components should be available in
case of an unexpected need.
INTRAOPERATIVE
Extreme caution should be used around the spinal cord and nerve roots. Damage to the nerves will cause loss of
neurological functions.
Breakage, slippage, or misuse of instruments or implant components may cause injury to the patient or operative personnel.Rods should not be repeatedly or excessively bent. Rods should not be reverse bent in the same location. Use great care to
ensure implant surfaces are not scratched or notched since such actions may reduce the functional strength of the construct. If rods are cut to length, they should be cut in such a way as to create a flat, non-sharp surface perpendicular to the midline of the rod. Cut the rods outside the operative field. Whenever possible, use pre-cut rods of the length needed.
Refer to the CD Horizon™ Fenestrated Screw surgical technique for procedural steps prior to inserting CD Horizon™
Fenestrated Screws.
When using these cement-augmented screws, connect the enclosed adapter to the screw, then connect the universal
handle to the adapter.
Insert all of the screws. Use great care to ensure the implant surfaces are not scratched or notched, since such actions may
reduce the functional strength of the construct.
Depending on the cement chosen, prepare in accordance with either the Medtronic HV-R™ Fenestrated Screw Cement or
Kyphon™ Xpede™ Bone Cement instructions for use. Refer to the Medtronic HV-R™ Fenestrated Screw Cement or Kyphon™ Xpede™ Bone Cement, instructions for use for a complete review of all warnings and precautions. After the cement is prepared, immediately load the cement injecting devices per individual system surgical techniques.
It is recommended that a maximum of 1.8cc of cement be injected in the vertebral body for each CD Horizon™ Fenestrated
Screw from T11 to L5 and maximum of 0.8cc of cement be used for each CD Horizon™ Fenestrated Screw used from T1 to T10 of the thoracic spine.
Note: the volume of cement used in CD Horizon™ Fenestrated Screw implants should ultimately be determined by the surgeon based on the individual patient anatomy.
Imaging systems must be used while cement is being delivered.Inject the cement slowly. If any extravasation is seen, stop the injection process immediately.Once the cement has been delivered, complete the procedure following the remaining steps outlined in the CD Horizon™
Fenestrated Screw Set surgical technique.
Caution: do not over-tap or use a screw that is either too long or too large. Over-tapping, using an incorrectly sized screw,
or accidentally advancing the guidewire during tap or screw insertion, may cause nerve damage, hemorrhage, or the other possible adverse events listed in this package insert. If screws are being inserted into spinal pedicles, use as large a screw diameter as will fit into each pedicle.
Bone graft may be placed in the area where fusion may be desired.To ensure maximum stability, two or more Crosslink™ plates or DTT Transverse Links on two bilaterally placed, continuous
rods should be used whenever possible.
Before closing soft tissues, provisionally tighten (finger tighten) all nuts or non-cement augmented screws, especially
screws or nuts that have a break-off feature. Once this has been completed, go back and firmly tighten all non-cement augmented screws and nuts. Recheck the tightness of all nuts or screws after finishing to ensure none loosened during the tightening of the other nuts or screws. Failure to do so may cause loosening of the other components.
POSTOPERATIVE
The physician's postoperative directions, warnings to the patient, and corresponding patient compliance, are extremely
important.
Page 5
Detailed instructions on use and limitations of the device should be given to the patient. The patient must be warned that
bending, loosening, and/or breakage of device(s) are complications which may occur as a result of excessive or early weight-bearing or muscular activity. The risk of bending, loosening, or breakage of a temporary internal fixation device during postoperative rehabilitation may be increased if the patient is active, or if the patient is debilitated or demented. The patient should be warned to avoid falls or sudden jolts in spinal position.
To allow the maximum chances for a successful surgical result, the patient or devices should not be exposed to mechanical
vibrations or shock that may loosen the device construct. The patient should be warned of this possibility and instructed to limit and restrict physical activities, especially lifting and twisting motions and any type of sport participation.
As a precaution, before patients with implants receive any subsequent surgery (such as dental procedures), prophylactic
antibiotics may be considered, especially for high-risk patients.
CD Horizon™ Fenestrated Screw implants are temporary internal fixation devices. Internal fixation devices are designed to
stabilize the operative site during the normal healing process.
Any retrieved devices should be treated in such a manner that reuse in another surgical procedure is not possible. As with
all orthopedic implants, CD Horizon™ Fenestrated Screw components should never be reused under any circumstances.
PACKAGING
Devices can be supplied in sterile or non-sterile form. Packages for each of the components should be intact upon receipt. Once the seal on the sterile package has been broken, the product should not be re-sterilized. If a loaner or consignment system is used, all sets should be carefully checked for completeness and all components including instruments should be carefully checked to ensure there is no damage prior to use. Damaged packages or products should not be used and should be returned to Medtronic.
All products should be treated with care. Improper use or handling may lead to damage and/or possible improper functioning of the device.
STERILIZATION
Unless marked sterile and clearly labeled as such in an unopened sterile package provided by the company, all implants must be sterilized prior to use. Remove all packaging materials prior to sterilization. Only sterile products should be placed in the operative field. Unless specified elsewhere, these products are recommended to be steam sterilized using one of the sets of process parameters listed in Table 1.
Table 1: Sterilization cycle parameters for the US and its territories
Method Cycle Temperature Exposure time
Steam Dynamic-air-removal 270°F (132°C) 4 Minutes 30 Minutes Steam Dynamic-air-removal 275°F (135°C) 3 Minutes 30 Minutes
For medical facilities located outside the US and its territories, some non-US health care authorities recommend sterilization according to these parameters to minimize the risk of transmission of Creutzfeldt-Jakob disease, especially of surgical instruments that could come into contact with the central nervous system.
Table 2: Sterilization cycle parameters for medical facilities outside the US and its territories
Method Cycle Temperature Exposure time
Steam Dynamic-air-removal 273°F (134°C) 4 Minutes 30 Minutes Steam Dynamic-air-removal 273°F (134°C) 20 Minutes 30 Minutes
1
Minimum dry times were validated using sterilizers having vacuum drying capabilities. Drying cycles using ambient
atmospheric pressure may require longer dry times. Refer to the sterilizer manufacturer’s recommendations.
Note: because of the many variables involved in sterilization, each medical facility should calibrate and verify the sterilization process (e.g. temperatures, times) used for their equipment.
Minimum dry time
Minimum dry time
1
1
PRODUCT COMPLAINTS
To report any product problems, contact Medtronic.
MRI INFORMATION
The CD Horizon™ Fenestrated Screw Set has not been evaluated for safety and compatibility in the MR environment. It has not been tested for heating, migration, or image artifact in the MR environment. The safety of CD Horizon™ Fenestrated Screw Set in the MR environment is unknown. Scanning a patient who has this device may result in patient injury.”
FURTHER INFORMATION
Recommended directions for use of this system (surgical operative techniques) are available at no charge upon request. If further information is needed or required, contact Medtronic.
©2020 Medtronic Sofamor Danek USA, Inc. All rights reserved.
Page 6
Medtronic Sofamor Danek USA, Inc.
1800 Pyramid Place Memphis, TN 38132 Telephone: 800 933 2635 (USA)
901 396 3133 (Outside USA)
Fax: 901 396 0356
EXPLANATION OF SYMBOLS
CAUTION: Federal law (USA) restricts these devices to sale by or on the order of a physician.
Do not re-use
Batch code
Manufacturer
Catalogue number
Non-sterile
For US audiences only
Consult instructions for use at this website.
Loading...